| Specialty Retail Industry | Consumer Discretionary Sector | Ms. Nandini Ajay Piramal CEO | MSE Exchange | INE0DK501011 ISIN |
| IN Country | 6,295 Employees | 16 Jul 2025 Last Dividend | - Last Split | - IPO Date |
Piramal Pharma Limited, established in 2020, marks its presence in the pharmaceutical industry by offering a wide range of products and comprehensive services. With its headquarters in Mumbai, India, the company quickly asserted itself as a significant player in the pharma sector. Operating as a subsidiary of Piramal Enterprises Limited, Piramal Pharma Limited delivers excellence and innovation, focusing on meeting the diverse needs of its customers globally. Its foundation is built on a strong ethos of quality, integrity, and groundbreaking healthcare solutions, aiming to contribute significantly to the well-being of individuals around the world.
The core offerings of Piramal Pharma Limited include a comprehensive portfolio of pharmaceutical products. These products encompass a variety of therapeutic areas, aiming to address the pressing health concerns of today. With a commitment to quality and efficacy, the company ensures that its products meet the highest standards, catering to the global market with unparalleled excellence.
Recognizing the critical role of injections in the administration of treatments, Piramal Pharma Limited provides specialized injection services. This service comprises the development and manufacturing of injectable formulations, ensuring safe, effective, and high-quality delivery mechanisms for medications. Catering to diverse medical fields, these services underscore the company's commitment to innovative solutions in pharma logistics and administration.
High Potency Active Pharmaceutical Ingredients (HPAPIs) represent another cornerstone of Piramal Pharma Limited's offerings. The company's capabilities in handling HPAPIs demonstrate its expertise in the pharmaceutical manufacturing domain, particularly in producing potent substances that require additional care in production and handling. With a focus on safety and quality, Piramal Pharma Limited supports the development of cutting-edge treatments for severe diseases, making significant contributions to the advancement of medical science.